Home Cart Sign in  
Chemical Structure| 1174046-72-0 Chemical Structure| 1174046-72-0

Structure of BMS-794833
CAS No.: 1174046-72-0

Chemical Structure| 1174046-72-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BMS-794833 is a potent ATP competitive inhibitor of Met and VEGFR2 with IC50 of 1.7 and 15 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BMS-794833

CAS No. :1174046-72-0
Formula : C23H15ClF2N4O3
M.W : 468.84
SMILES Code : O=C(C1=CNC=C(C2=CC=C(F)C=C2)C1=O)NC3=CC=C(OC4=C(Cl)C(N)=NC=C4)C(F)=C3
MDL No. :MFCD18206786
InChI Key :PDYXPCKITKHFOZ-UHFFFAOYSA-N
Pubchem ID :44155856

Safety of BMS-794833

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of BMS-794833

RTK

Isoform Comparison

Biological Activity

Target
  • VEGFR2

    VEGFR2, IC50:15 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
4T1 cells 10 μM BMS-794833 inhibited the proliferation of 4T1 cells. Cancer Res. 2022 Feb 1;82(3):433-446
THP-1 cells 7.5 μM 3 days BMS-794833 significantly inhibited THP-1-derived macrophage polarization, reduced cellular elongation, and promoted an inflammatory phenotype. Cancer Res. 2022 Feb 1;82(3):433-446
MG63 10 μM, 20 μM 24 h BMS-794833 significantly improved the resistance of osteosarcoma cells to anlotinib. J Bone Oncol. 2024 Mar 16;45:100594

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Triple-negative breast cancer model Intratumoral injection 25 mg/kg Twice weekly until the experimental endpoint BMS-794833 significantly suppressed tumor growth and metastasis, and reduced the anti-inflammatory phenotype of tumor-associated macrophages. Cancer Res. 2022 Feb 1;82(3):433-446
BALB/C nude mice Osteosarcoma xenograft model Oral 10 mg/kg 28 days BMS-794833 and anlotinib exerted synergistic therapeutic effects against osteosarcoma in vivo. J Bone Oncol. 2024 Mar 16;45:100594

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.13mL

0.43mL

0.21mL

10.66mL

2.13mL

1.07mL

21.33mL

4.27mL

2.13mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories